Unlock instant, AI-driven research and patent intelligence for your innovation.

CEA detection kit based on bimolecular fluorescence complementation technology, preparation method and use method thereof

A detection kit and bimolecular technology, applied in the field of bimolecular fluorescence complementation, can solve the problems of long operation time, radioactive contamination, and reduction of reagent precision in enzyme-linked immunosorbent assay.

Inactive Publication Date: 2018-08-10
NANJING TZONE BIOLOGICAL SCI & TECH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The enzyme-linked immunosorbent assay takes a long time to operate, the process needs to be cleaned, and the steps are cumbersome
The disadvantage of radioimmunity method is that it produces radioactive pollution and the waste disposal is complicated
Magnetic particle chemiluminescence is a heterogeneous reaction, and cleaning is required during the operation, which reduces the precision of the reagents

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • CEA detection kit based on bimolecular fluorescence complementation technology, preparation method and use method thereof
  • CEA detection kit based on bimolecular fluorescence complementation technology, preparation method and use method thereof
  • CEA detection kit based on bimolecular fluorescence complementation technology, preparation method and use method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] The anti-CEA antibody is coupled to the N-terminal fragment of fluorescent protein, taking the yellow fluorescent protein (YFP) 1-154 amino acid fragment YFPN as an example, the specific implementation process is as follows:

[0029] 1) Add 0.1mg of YFPN protein into a centrifuge tube, and prepare with 0.05mol / L pH9.5 carbonate buffer (CB) to dilute the YFPN protein to 1mg / mL.

[0030] 2) Add glutaraldehyde at a final concentration of 1.25% in a fume hood.

[0031] 3) Reaction in a water bath at 37°C for 2 hours.

[0032] 4) Dialyze with desalting column Sephadex G-25 or 0.05mol / L pH9.5 CB to remove excess glutaraldehyde.

[0033] 5) Take 0.1mg anti-CEA antibody, prepare 1mg / mL antibody with 0.05mol / L pH9.5 CB, and mix the activated YFPN protein and antibody.

[0034] 6) React overnight at 4°C.

[0035] 7) Blocking: add 50 μL of 0.2 mol / L lysine solution, and block for 2 hours at room temperature to block residual aldehyde groups and terminate the reaction.

[0036]...

Embodiment 2

[0039] The anti-CEA antibody is coupled to the fluorescent protein C-terminal fragment, taking the yellow fluorescent protein (YFP) 155-238 amino acid fragment YFPC as an example, the specific implementation process is as follows:

[0040] 1) Add 0.1mg of YFPC protein into a centrifuge tube, and prepare with 0.05mol / L pH9.5 carbonate buffer (CB) to dilute the YFPC protein to 1mg / mL.

[0041] 2) Add glutaraldehyde at a final concentration of 1.25% in a fume hood.

[0042] 3) Reaction in a water bath at 37°C for 2 hours.

[0043] 4) Dialyze with desalting column Sephadex G-25 or 0.05mol / L pH9.5CB to remove excess glutaraldehyde.

[0044] 5) Take 0.1mg of anti-CEA antibody, prepare 1mg / mL antibody with 0.05mol / L pH9.5 CB, and mix the activated YFPC protein and antibody.

[0045] 6) React overnight at 4°C.

[0046] 7) Blocking: add 50 μL of 0.2 mol / L lysine solution, and block for 2 hours at room temperature to block residual aldehyde groups and terminate the reaction.

[0047...

Embodiment 3

[0050] The main components of the kit:

[0051] 1) N-terminal fragment of fluorescent protein coupled with anti-CEA antibody;

[0052] 2) C-terminal fragment of fluorescent protein coupled with anti-CEA antibody.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Analytical sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention provides a CEA diagnosis kit based on a bimolecular fluorescence complementation technology, wherein the kit comprises an anti-CEA antibody conjugated fluorescent protein N-terminal fragment and an anti-CEA antibody conjugated fluorescent protein C-terminal fragment. The invention further discloses a preparation method of the CEA diagnosis kit, wherein the preparation method comprises: preparation of an anti-CEA antibody conjugated fluorescent protein N-terminal fragment, and preparation of an anti-CEA antibody conjugated fluorescent protein C-terminal fragment. The invention further discloses a use method the kit. According to the present invention, the kit has advantages of simple operation, no cleaning, high precision, high accuracy and the like, is conveniently suitable for clinical detection, can increase the accuracy of the diagnosis of tumors in the monitoring of tumors, and has great market value.

Description

technical field [0001] The invention relates to a bimolecular fluorescence complementary technology used for in vitro immunodiagnosis to detect the content of CEA in a human body, belonging to the field of disease diagnosis and detection. Background technique [0002] Carcino-embryonic antigen (CEA) is a proteoglycan complex present in colon cancer, normal embryonic intestine, pancreas and liver. It can be widely found in digestive system cancers of endoderm origin, also in the digestive tract tissue of normal embryos, and can also exist in trace amounts in normal human serum. [0003] CEA was originally found in colon cancer and fetal intestinal tissue, hence the name carcinoembryonic antigen. Elevated CEA is common in colorectal cancer, pancreatic cancer, gastric cancer, small cell lung cancer, breast cancer, and medullary thyroid cancer. But smoking, pregnancy, cardiovascular disease, diabetes, non-specific colitis and other diseases, 15%-53% of patients will also have ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): G01N33/68G01N33/533G01N33/544
CPCG01N33/533G01N33/544G01N33/6893
Inventor 徐林
Owner NANJING TZONE BIOLOGICAL SCI & TECH